Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.

Quattrone A, Morelli M, Nigro S, Quattrone A, Vescio B, Arabia G, Nicoletti G, Nisticò R, Salsone M, Novellino F, Barbagallo G, Le Piane E, Pugliese P, Bosco D, Vaccaro MG, Chiriaco C, Sabatini U, Vescio V, Stanà C, Rocca F, Gullà D, Caracciolo M.

Parkinsonism Relat Disord. 2018 Jul 25. pii: S1353-8020(18)30327-4. doi: 10.1016/j.parkreldis.2018.07.016. [Epub ahead of print]

PMID:
30068492
2.

Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.

Barone S, Caligiuri ME, Valentino P, Cherubini A, Chiriaco C, Granata A, Filippelli E, Tallarico T, Nisticò R, Quattrone A.

J Neurol. 2018 Jul 26. doi: 10.1007/s00415-018-8980-y. [Epub ahead of print]

PMID:
30051273
3.

New Insights on the Photodegradation of Caffeine in the Presence of Bio-Based Substances-Magnetic Iron Oxide Hybrid Nanomaterials.

Palma D, Bianco Prevot A, Brigante M, Fabbri D, Magnacca G, Richard C, Mailhot G, Nisticò R.

Materials (Basel). 2018 Jun 26;11(7). pii: E1084. doi: 10.3390/ma11071084.

4.

Precision medicine and drug development in Alzheimer's disease: the importance of sexual dimorphism and patient stratification.

Hampel H, Vergallo A, Giorgi FS, Kim SH, Depypere H, Graziani M, Saidi A, Nisticò R, Lista S; Alzheimer Precision Medicine Initiative (APMI).

Front Neuroendocrinol. 2018 Jun 12. pii: S0091-3022(18)30048-7. doi: 10.1016/j.yfrne.2018.06.001. [Epub ahead of print] Review.

PMID:
29902481
5.

Clinical, electrophysiological, and imaging study in essential tremor-Parkinson's disease syndrome.

Arabia G, Lupo A, Manfredini LI, Vescio B, Nisticò R, Barbagallo G, Salsone M, Morelli M, Novellino F, Nicoletti G, Quattrone A, Cascini GL, Louis ED, Quattrone A.

Parkinsonism Relat Disord. 2018 Jun 5. pii: S1353-8020(18)30264-5. doi: 10.1016/j.parkreldis.2018.06.005. [Epub ahead of print]

PMID:
29885986
6.

Mutational analysis of TARDBP gene in patients affected by Parkinson's disease from Calabria.

Gagliardi M, Arabia G, Nisticò R, Iannello G, Procopio R, Manfredini L, Annesi G, Quattrone A.

J Neurol Sci. 2018 Jul 15;390:209-211. doi: 10.1016/j.jns.2018.04.043. Epub 2018 May 1.

PMID:
29801890
7.

Midbrain meningioma causing subacute parkinsonism.

Labate A, Nisticò R, Cherubini A, Quattrone A.

Neurol Clin Pract. 2018 Apr;8(2):166-168. doi: 10.1212/CPJ.0000000000000439. No abstract available.

PMID:
29708227
8.

Targeting mGlu5 Metabotropic Glutamate Receptors in the Treatment of Cognitive Dysfunction in a Mouse Model of Phenylketonuria.

Nardecchia F, Orlando R, Iacovelli L, Colamartino M, Fiori E, Leuzzi V, Piccinin S, Nistico R, Puglisi-Allegra S, Di Menna L, Battaglia G, Nicoletti F, Pascucci T.

Front Neurosci. 2018 Mar 16;12:154. doi: 10.3389/fnins.2018.00154. eCollection 2018.

9.

From biowaste to magnet-responsive materials for water remediation from polycyclic aromatic hydrocarbons.

Nisticò R, Cesano F, Franzoso F, Magnacca G, Scarano D, Funes IG, Carlos L, Parolo ME.

Chemosphere. 2018 Jul;202:686-693. doi: 10.1016/j.chemosphere.2018.03.153. Epub 2018 Mar 23.

PMID:
29602101
10.

Role of ASIC1a in Aβ-induced synaptic alterations in the hippocampus.

Mango D, Nisticò R.

Pharmacol Res. 2018 May;131:61-65. doi: 10.1016/j.phrs.2018.03.016. Epub 2018 Mar 21.

PMID:
29574226
11.

Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.

Hampel H, Toschi N, Babiloni C, Baldacci F, Black KL, Bokde ALW, Bun RS, Cacciola F, Cavedo E, Chiesa PA, Colliot O, Coman CM, Dubois B, Duggento A, Durrleman S, Ferretti MT, George N, Genthon R, Habert MO, Herholz K, Koronyo Y, Koronyo-Hamaoui M, Lamari F, Langevin T, Lehéricy S, Lorenceau J, Neri C, Nisticò R, Nyasse-Messene F, Ritchie C, Rossi S, Santarnecchi E, Sporns O, Verdooner SR, Vergallo A, Villain N, Younesi E, Garaci F, Lista S; Alzheimer Precision Medicine Initiative (APMI).

J Alzheimers Dis. 2018;64(s1):S47-S105. doi: 10.3233/JAD-179932.

12.

The placebo effect on resting tremor in Parkinson's disease: an electrophysiological study.

Barbagallo G, Nisticò R, Vescio B, Cerasa A, Olivadese G, Nigro S, Crasà M, Quattrone A, Bianco MG, Morelli M, Augimeri A, Salsone M, Novellino F, Nicoletti G, Arabia G, Quattrone A.

Parkinsonism Relat Disord. 2018 Jul;52:17-23. doi: 10.1016/j.parkreldis.2018.03.012. Epub 2018 Mar 14.

PMID:
29551396
13.

AD-Related N-Terminal Truncated Tau Is Sufficient to Recapitulate In Vivo the Early Perturbations of Human Neuropathology: Implications for Immunotherapy.

Borreca A, Latina V, Corsetti V, Middei S, Piccinin S, Della Valle F, Bussani R, Ammassari-Teule M, Nisticò R, Calissano P, Amadoro G.

Mol Neurobiol. 2018 Mar 5. doi: 10.1007/s12035-018-0974-3. [Epub ahead of print]

PMID:
29508283
14.

Early alteration of distribution and activity of hippocampal type-1 cannabinoid receptor in Alzheimer's disease-like mice overexpressing the human mutant amyloid precursor protein.

Maccarrone M, Totaro A, Leuti A, Giacovazzo G, Scipioni L, Mango D, Coccurello R, Nisticò R, Oddi S.

Pharmacol Res. 2018 Apr;130:366-373. doi: 10.1016/j.phrs.2018.02.009. Epub 2018 Feb 14.

PMID:
29454025
15.

Neuregulin 1/ErbB signalling modulates hippocampal mGluRI-dependent LTD and object recognition memory.

Ledonne A, Mango D, Latagliata EC, Chiacchierini G, Nobili A, Nisticò R, D'Amelio M, Puglisi-Allegra S, Mercuri NB.

Pharmacol Res. 2018 Apr;130:12-24. doi: 10.1016/j.phrs.2018.02.003. Epub 2018 Feb 7.

PMID:
29427771
16.

PDGF Modulates Synaptic Excitability and Short-Latency Afferent Inhibition in Multiple Sclerosis.

Mango D, Nisticò R, Furlan R, Finardi A, Centonze D, Mori F.

Neurochem Res. 2018 Feb 1. doi: 10.1007/s11064-018-2484-0. [Epub ahead of print]

PMID:
29392518
17.

Bromelain Degrades Aβ1-42 Monomers and Soluble Aggregates: An In Vitro Study in Cerebrospinal Fluid of Alzheimer's Disease Patients.

Sancesario GM, Nuccetelli M, Cerri A, Zegeer J, Severini C, Ciotti MT, Pieri M, Martorana A, Caltagirone C, Nistico R, Bernardini S.

Curr Alzheimer Res. 2018;15(7):628-636. doi: 10.2174/1567205015666180123124851.

PMID:
29359669
18.

Increased glutamate + glutamine levels in the thalamus of patients with essential tremor: A preliminary proton MR spectroscopic study.

Barbagallo G, Arabia G, Novellino F, Nisticò R, Salsone M, Morelli M, Rocca F, Quattrone A, Caracciolo M, Sabatini U, Cherubini A, Quattrone A.

Parkinsonism Relat Disord. 2018 Feb;47:57-63. doi: 10.1016/j.parkreldis.2017.11.345. Epub 2017 Nov 28.

PMID:
29203059
19.

Sustainable magnet-responsive nanomaterials for the removal of arsenic from contaminated water.

Nisticò R, Celi LR, Bianco Prevot A, Carlos L, Magnacca G, Zanzo E, Martin M.

J Hazard Mater. 2018 Jan 15;342:260-269. doi: 10.1016/j.jhazmat.2017.08.034. Epub 2017 Aug 18.

PMID:
28843795
20.

Recovery of hippocampal functions and modulation of muscarinic response by electroacupuncture in young diabetic rats.

Soligo M, Piccinin S, Protto V, Gelfo F, De Stefano ME, Florenzano F, Berretta E, Petrosini L, Nisticò R, Manni L.

Sci Rep. 2017 Aug 22;7(1):9077. doi: 10.1038/s41598-017-08556-z.

21.

Thalamic neurometabolic alterations in tremulous Parkinson's disease: A preliminary proton MR spectroscopy study.

Barbagallo G, Arabia G, Morelli M, Nisticò R, Novellino F, Salsone M, Rocca F, Quattrone A, Caracciolo M, Sabatini U, Cherubini A, Quattrone A.

Parkinsonism Relat Disord. 2017 Oct;43:78-84. doi: 10.1016/j.parkreldis.2017.07.028. Epub 2017 Jul 28.

PMID:
28774469
22.

Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study.

Lista S, Toschi N, Baldacci F, Zetterberg H, Blennow K, Kilimann I, Teipel SJ, Cavedo E, Dos Santos AM, Epelbaum S, Lamari F, Dubois B, Nisticò R, Floris R, Garaci F, Hampel H; Alzheimer Precision Medicine Initiative (APMI).

J Alzheimers Dis. 2017;59(4):1327-1334. doi: 10.3233/JAD-170368.

PMID:
28731449
23.

Structural connectivity differences in essential tremor with and without resting tremor.

Caligiuri ME, Arabia G, Barbagallo G, Lupo A, Morelli M, Nisticò R, Novellino F, Quattrone A, Salsone M, Vescio B, Cherubini A, Quattrone A.

J Neurol. 2017 Sep;264(9):1865-1874. doi: 10.1007/s00415-017-8553-5. Epub 2017 Jul 20.

PMID:
28730570
24.

Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative group.

Concolino D, Amico L, Cappellini MD, Cassinerio E, Conti M, Donati MA, Falvo F, Fiumara A, Maccarone M, Manna R, Matucci A, Musumeci MB, Nicoletti A, Nisticò R, Papadia F, Parini R, Peluso D, Pensabene L, Pisani A, Pistone G, Rigoldi M, Romani I, Tenuta M, Torti G, Veroux M, Zachara E.

Mol Genet Metab Rep. 2017 Jun 22;12:85-91. doi: 10.1016/j.ymgmr.2017.06.005. eCollection 2017 Sep.

25.

Unlocking the secrets of dopamine in Alzheimer's Disease.

D'Amelio M, Nisticò R.

Pharmacol Res. 2018 Feb;128:399. doi: 10.1016/j.phrs.2017.06.018. Epub 2017 Jun 30. No abstract available.

PMID:
28669711
26.

Synaptoimmunology - roles in health and disease.

Nisticò R, Salter E, Nicolas C, Feligioni M, Mango D, Bortolotto ZA, Gressens P, Collingridge GL, Peineau S.

Mol Brain. 2017 Jun 20;10(1):26. doi: 10.1186/s13041-017-0308-9. Review.

27.

Structural connectivity differences in motor network between tremor-dominant and nontremor Parkinson's disease.

Barbagallo G, Caligiuri ME, Arabia G, Cherubini A, Lupo A, Nisticò R, Salsone M, Novellino F, Morelli M, Cascini GL, Galea D, Quattrone A.

Hum Brain Mapp. 2017 Sep;38(9):4716-4729. doi: 10.1002/hbm.23697. Epub 2017 Jun 20.

PMID:
28631404
28.

Camptocormia as presenting in lower motor neuron disease with TARDBP mutation: case report.

Filippelli E, Valentino P, Annesi G, Nisticò R, Quattrone A.

Neurol Sci. 2017 Oct;38(10):1885-1887. doi: 10.1007/s10072-017-3005-7. Epub 2017 Jun 1. No abstract available.

PMID:
28573484
29.

Reactive Hypersaline Route: One-Pot Synthesis of Porous Photoactive Nanocomposites.

Nisticò R, Tabasso S, Magnacca G, Jordan T, Shalom M, Fechler N.

Langmuir. 2017 May 30;33(21):5213-5222. doi: 10.1021/acs.langmuir.7b00142. Epub 2017 May 16.

PMID:
28489387
30.

Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease?

Nigro S, Morelli M, Arabia G, Nisticò R, Novellino F, Salsone M, Rocca F, Quattrone A.

Parkinsonism Relat Disord. 2017 Aug;41:31-36. doi: 10.1016/j.parkreldis.2017.05.002. Epub 2017 May 3.

PMID:
28487107
31.

The Involvement of Post-Translational Modifications in Alzheimer's Disease.

Marcelli S, Corbo M, Iannuzzi F, Negri L, Blandini F, Nistico R, Feligioni M.

Curr Alzheimer Res. 2018 Feb 22;15(4):313-335. doi: 10.2174/1567205014666170505095109.

PMID:
28474569
32.

Unbalance between Excitation and Inhibition in Phenylketonuria, a Genetic Metabolic Disease Associated with Autism.

De Jaco A, Mango D, De Angelis F, Favaloro FL, Andolina D, Nisticò R, Fiori E, Colamartino M, Pascucci T.

Int J Mol Sci. 2017 Apr 29;18(5). pii: E941. doi: 10.3390/ijms18050941.

33.

PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease.

Hampel H, O'Bryant SE, Castrillo JI, Ritchie C, Rojkova K, Broich K, Benda N, Nisticò R, Frank RA, Dubois B, Escott-Price V, Lista S.

J Prev Alzheimers Dis. 2016 Dec;3(4):243-259. doi: 10.14283/jpad.2016.112. Epub 2016 Sep 6.

34.

The role of adiponectin receptors in the regulation of synaptic transmission in the hippocampus.

Weisz F, Piccinin S, Mango D, Ngomba RT, Mercuri NB, Nicoletti F, Nisticò R.

Synapse. 2017 May;71(5). doi: 10.1002/syn.21964. Epub 2017 Feb 21.

PMID:
28187508
35.

Acid-sensing ion channel 1a is required for mGlu receptor dependent long-term depression in the hippocampus.

Mango D, Braksator E, Battaglia G, Marcelli S, Mercuri NB, Feligioni M, Nicoletti F, Bashir ZI, Nisticò R.

Pharmacol Res. 2017 May;119:12-19. doi: 10.1016/j.phrs.2017.01.028. Epub 2017 Jan 27.

PMID:
28137639
36.

Prokineticin system modulation as a new target to counteract the amyloid beta toxicity induced by glutamatergic alterations in an in vitro model of Alzheimer's disease.

Caioli S, Severini C, Ciotti T, Florenzano F, Pimpinella D, Petrocchi Passeri P, Balboni G, Polisca P, Lattanzi R, Nisticò R, Negri L, Zona C.

Neuropharmacology. 2017 Apr;116:82-97. doi: 10.1016/j.neuropharm.2016.12.012. Epub 2016 Dec 15.

PMID:
27989680
37.

Ginkgolic Acid Protects against Aβ-Induced Synaptic Dysfunction in the Hippocampus.

Mango D, Weisz F, Nisticò R.

Front Pharmacol. 2016 Oct 26;7:401. eCollection 2016.

38.
39.

Targeting SUMO-1ylation Contrasts Synaptic Dysfunction in a Mouse Model of Alzheimer's Disease.

Marcelli S, Ficulle E, Iannuzzi F, Kövari E, Nisticò R, Feligioni M.

Mol Neurobiol. 2017 Oct;54(8):6609-6623. doi: 10.1007/s12035-016-0176-9. Epub 2016 Oct 13. Review.

PMID:
27738871
40.

Heart rate variability in patients with essential tremor: A cross sectional study.

Salsone M, Nistico' R, Vescio B, Novellino F, Morelli M, Lupo A, Arabia G, Quattrone A.

Parkinsonism Relat Disord. 2016 Dec;33:134-137. doi: 10.1016/j.parkreldis.2016.09.027. Epub 2016 Sep 28.

PMID:
27697369
41.

Urban biowaste-derived sensitizing materials for caffeine photodegradation.

Bianco Prevot A, Baino F, Fabbri D, Franzoso F, Magnacca G, Nisticò R, Arques A.

Environ Sci Pollut Res Int. 2017 May;24(14):12599-12607. doi: 10.1007/s11356-016-7763-1. Epub 2016 Sep 30.

PMID:
27696166
42.

The corticospinal tract profile in amyotrophic lateral sclerosis.

Sarica A, Cerasa A, Valentino P, Yeatman J, Trotta M, Barone S, Granata A, Nisticò R, Perrotta P, Pucci F, Quattrone A.

Hum Brain Mapp. 2017 Feb;38(2):727-739. doi: 10.1002/hbm.23412. Epub 2016 Sep 23.

PMID:
27659483
43.

MR parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP-parkinsonism.

Quattrone A, Morelli M, Williams DR, Vescio B, Arabia G, Nigro S, Nicoletti G, Salsone M, Novellino F, Nisticò R, Pucci F, Chiriaco C, Pugliese P, Bosco D, Caracciolo M.

Neurology. 2016 Sep 20;87(12):1266-73. doi: 10.1212/WNL.0000000000003125. Epub 2016 Aug 24.

44.

Characterizing structural neural networks in de novo Parkinson disease patients using diffusion tensor imaging.

Nigro S, Riccelli R, Passamonti L, Arabia G, Morelli M, Nisticò R, Novellino F, Salsone M, Barbagallo G, Quattrone A.

Hum Brain Mapp. 2016 Dec;37(12):4500-4510. doi: 10.1002/hbm.23324. Epub 2016 Jul 28.

PMID:
27466157
45.

Study of the adhesive properties versus stability/aging of hernia repair meshes after deposition of RF activated plasma polymerized acrylic acid coating.

Rivolo P, Nisticò R, Barone F, Faga MG, Duraccio D, Martorana S, Ricciardi S, Magnacca G.

Mater Sci Eng C Mater Biol Appl. 2016 Aug 1;65:287-94. doi: 10.1016/j.msec.2016.04.049. Epub 2016 Apr 19.

PMID:
27157754
46.

Gender difference in prescription opioid abuse: A focus on oxycodone and hydrocodone.

Graziani M, Nisticò R.

Pharmacol Res. 2016 Jun;108:31-38. doi: 10.1016/j.phrs.2016.04.012. Epub 2016 Apr 20. Review.

PMID:
27107788
47.

NGF controls APP cleavage by downregulating APP phosphorylation at Thr668: relevance for Alzheimer's disease.

Triaca V, Sposato V, Bolasco G, Ciotti MT, Pelicci P, Bruni AC, Cupidi C, Maletta R, Feligioni M, Nisticò R, Canu N, Calissano P.

Aging Cell. 2016 Aug;15(4):661-72. doi: 10.1111/acel.12473. Epub 2016 Apr 13.

48.

Cerebellar involvement in essential tremor with and without resting tremor: A Diffusion Tensor Imaging study.

Novellino F, Nicoletti G, Cherubini A, Caligiuri ME, Nisticò R, Salsone M, Morelli M, Arabia G, Cavalli SM, Vaccaro MG, Chiriaco C, Quattrone A.

Parkinsonism Relat Disord. 2016 Jun;27:61-6. doi: 10.1016/j.parkreldis.2016.03.022. Epub 2016 Mar 30.

PMID:
27050442
49.

Tremor pattern differentiates drug-induced resting tremor from Parkinson disease.

Nisticò R, Fratto A, Vescio B, Arabia G, Sciacca G, Morelli M, Labate A, Salsone M, Novellino F, Nicoletti A, Petralia A, Gambardella A, Zappia M, Quattrone A.

Parkinsonism Relat Disord. 2016 Apr;25:100-3. doi: 10.1016/j.parkreldis.2016.02.002. Epub 2016 Feb 3.

PMID:
26895708
50.

Alterations of putaminal shape in de novo Parkinson's disease.

Caligiuri ME, Nisticò R, Arabia G, Morelli M, Novellino F, Salsone M, Barbagallo G, Lupo A, Cascini GL, Galea D, Cherubini A, Quattrone A.

Mov Disord. 2016 May;31(5):676-83. doi: 10.1002/mds.26550. Epub 2016 Feb 16.

PMID:
26879753

Supplemental Content

Loading ...
Support Center